Specialized Graduate School Science & Technology Convergence Dept. of Marine-Bio. Conbergence Science / Marine Bioprocess Researh Center Pukyong National University, Busan
“To lose one’s property is to lose a little.
To lose one’s honor is to lose much.
But, to lose one’s health is to lose everything.”
2 The relationship between mortality rate and the consumption frequency of fish and shellfish
Intake frequency of fish and shellfish Cause of death Everyday Often Sometimes Never Neuronal death 1.0 1.08 1.10 1.10 Heart diseases 1.0 1.09 1.13 1.24 Hyperplasia 1.0 1.55 1.89 1.79 Liver cirrhosis 1.0 1.21 1.30 1.74 Stomach cancer 1.0 1.04 1.04 1.44 Liver cancer 1.0 1.03 1.16 2.62 Uterine cancer 1.0 1.28 1.71 2.37 Total death 1.0 1.07 1.12 1.32 Number of investigative subjects 1,412,740 2186,368 203,945 28,943
Institute of preventive cancer in Japan (45;3, 1992) Investigation period: 17 years 3 Development of oriental medicine from marine organism
Traditional Oriental-Chinese Medicinal Database
There are number of terrestrial plants and animals cited in the book on oriental medicine
Plants : 7815 species Animals: 1050 species
Marine organism
Plants : 40 species Coral : 12 species Animals : 134 species Below 10 species are utilized at present
There is a great deal of interest and potential to make use of these marine bio-resources through marine biotechnology research, for the development of drugs which could be used in various medicinal applications.
1. Classification: Ecklonia cava is a brown alga (Laminariaceae)
2. Habitat: Jeju island in Korea.
3. Efficacy: Antitumor, MMPs inhibitory, Anti-inflammation, Anti-HIV Anti-osteoarthritis, Antioxidant activity
4. Active Ingredients: Phlorotannins such as eckol, 6,6’-bieckol , dieckol phlorofucofuroeckol
5 Phlorotannin compounds isolated from Ecklonia cava
Fucodiphloroethol G Dieckol
6,6’- bieckol 7-phloroeckol
Phlorofucocuroeckol-A Dioxinodehydroeckol
6 Biological activities of Ecklonia cava…
Matrix metalloproteinase inhibitory activity Anti-inflammatory activity Anti-HIV activity Anti-asthma activity Anti-allergy activity
7 Matrix metalloproteinase (MMP)
Matrix metalloproteinase (MMP)
Secreted or transmembrane endopeptidases MMP Substrates: fibrillar and non-fibrillar collagens, fibronectin, laminin, elastin and basement membrane glycoproteins Calcium and zinc dependent endopeptidase
MMP functions: - Metastasis - Angiogenesis - Arthritis - Wound healing - Periodontal disease - Osteoporosis Ca Zn - Wrinkle formation - Chronic inflammation
MMPs are a group of endopeptidase that mainly involve in the degradation of cellular matrix 8 Matrix metalloproteinase (MMP)
9 MMP inhibitors in Clinical development
FDA approved
10 Preliminary screening of MMP inhibitors from algae extracts
DCL : Doxycycline, positive control
Weight EtOH Scientific name yield (%) (g) Extract (g) DCL 1. Codium 1 1.63 0.0942 5.78 7 contractum 2. Ulva 10 0.127 1.27 conglobata Blank 2 6 3.Scinaia 2 0.031 1.55 okamurae 5 3 4.Ecklonia cava 10 0.9467 9.47 4 5. Ulva pertusa 4.5 0.0758 1.68 6.Enteromorpha 3.5 0.0134 0.38 compressa 7.Enteromorpha 2.63 0.1555 5.91 linza
Only collagenase treated blank group showed complete digestion of gelatin. Ecklonia cava extract showed strong inhibitory effect on gelatin digestion, same with doxycycline.
11 Effects of EC extract on MMP-2 and MMP-9 activities in HT1080 cells
PMA (Phorbol miristic acetate) : Stimulator of MMP
Ecklonia cava extract suppressed the expression and activation of MMP-2 and 9 dose-dependently in human fibrosarcoma cell.
12 Effects of eckol on PMA-induced protein expression of MMP-2 and 9 in HT1080 human fibrosarcoma
HO OH
EK 0 0 1 10 50 100 μM OH O O OH PMA - + + + + + MMP-2 O O HO OH OH MMP-9 OH O O OH β-actin HO O 4 OH Eckol PMA (Phorbol myristate acetate) : Stimulator of MMP
Eckol inhibits the expression of MMP-2 and 9 dose-dependently in human fibrosarcoma cells.
13 Effect of eckol on cell invasion in the HT1080 3D culture
0 h Blank 36 h 1 µM 36 h 10 µM
36 h Blank 36 h 50 µM 36 h 100µM
After 36 hours of eckol treatment, the highest concentration treatment showed the lower cell invasion. Eckol strongly suppressed tumor cell invasion due to inhibition of the degradation of cell matrix. Eckol, has great potential as natural MMP inhibitor in medicinal application. 14 Signalling pathway that lead to inflammation by NF-κB activation
NATURE REVIEWS IMMUNOLOGY 2005, 5; 749-759 15 Effect of eckol on LPS-induced NO and PGE2 production in RAW 264.7 mouse macrophage
50 180 # # 160 40 140 ** * ** 120 30 100
*** (pg/ml)
2 80 *** 20 NO (µM)NO
PGE 60 *** 10 40
20
0 0 EK (µM) 0 0 1 10 50 100 EK (µM) 0 0 1 10 50 100 LPS (1 µg/ml) - + + + + + LPS (1 µg/ml) - + + + + +
Nitric oxide (NO) and prostagradin E2 are the key mediators of early phase inflammation. Eckol decrease NO and PGE2 levels dose dependently.
16 Effects of eckol on LPS-induced protein (a) and mRNA (b) expressions of iNOS and COX-2 in RAW 264.7 macrophage
EK 0 0 1 10 50 100 μM LPS - + + + + + iNOS
COX-2 (a) β-actin
iNOS
COX-2 (b) GADPH
Eckol suprpessed the COX-2 and iNOS expression
17 Effects of eckol on NF-κB nuclear localization in LPS-stimulated RAW 264.7 macrophage under confocal microscope
NF-κB is a protein complex that controls the transcription of many inflammatory proteins.
NF-κB translocation to nucleus cause the transcription of these pre-imflammatory Blank FF 10 µM EK 10 µM cytokines and enzymes.
100 uM eckol stronlgly suppress NF-κB translocation to nucleus.
Eckol inhibit inflammation via suppressing the nuclear LPS EK 100 µM translocation of NF-kB.
18 Anti-HIV activity
19 Anti-retroviral agents for HIV
Four anti-HIV targets
Entry stage
Transcription of HIV RNA
Transcription of HIV DNA
Exit of newly formed viruses
20 HIV Entry
HIV-1 gp41
HIV-1 gp120 Envelope Glycoprotein
CD4
CXCR4 T-Cell Surface Gp120 of HIV-1 binds to CD4 cell surface receptor and CXCR4 co-receptor.
21 HIV Entry
HIV-1 gp41
gp120
CD4
CXCR4
T-Cell Surface First, Gp120 firstly binds to CD4 cell surface receptor.
22 HIV Entry
HIV-1 gp41
gp120
CD4
CXCR4
T-Cell Surface Gp120 binds to CXCR4 co-receptor, then, conformational change was happened in gp41.
23 HIV Entry
HIV-1
gp41
gp120
CD4
CXCR4
T-Cell Surface And eventually gp41 anchors the cell membrane.
24 HIV Entry
HIV-1 RNA
HIV-1 HIV-1 Nucleocapsid
T-Cell Surface Finally, the membrane of HIV and the host cell fuses, then, nucleocapsid of HIV-1 is transferred into the host cell.
25 Anti-HIV 1 activity of 6,6’-bieckol derived from Ecklonia Cava
Syncytia Formation 6,6’-bieckol from Ecklonia cava
Uninfected C8166 cells HIV-1RF infected C8166 cells forming syncytia
When an infected cell starts producing HIV proteins, the HIV envelope proteins migrate to the cell surface and neighbouring cells bind each other, forming syncytia.
26 Effects of 6,6’-bieckol on HIV-1 induced syncytia formation in C8166 cells
I. Blank (I) II. HIV-1RF infected control
Fluorescent microscope images of C8166 cells acutely infected with HIV-1.
Cells were labeled with a fluorescent agent after a III. 6,6’-bieckol 25 µM IV. 6,6’-bieckol 50 µM 3-day incubation period.
When bieckol was treated, syncytia formation was clearly inhibited. 27 Effect of 6,6’-bieckol on syncytia formation(A) and inhibition of HIV- 1 RT activity(B) in co-culture system
. RT: reverse transcriptase
6,6'-bieckol significantly inhibited the syncytia formation. In addition, the compound inhibited the RT-activity of HIV in the co-culture system. 6,6'-bieckol protects cells from HIV infection probably via inhibition of HIV gene expression. 28 Anti-asthma activity
29 Anti-asthma effects of Ecklonia cava extract in induced mouse asthma model Induced mouse asthma model Non- ovalbumin(OVA)
EC. extract
Normal tissue Induce asthma Allergic-reaction of respiratory tract • Cytokines
• IgE
• NF-κB
To evaluate the anti-asthma activity of EC extracts, we studied effects of EC extract on mucus secretion, allergic-reaction of respiratory tract and suppression of inflammatory markers
30 Ecklonia cava extracts inhibits pathological changes in lung tissues of asthma mouse
Blank Control EC. Extract OVA - OVA + OVA +
Control showed the mucus cell hypertrophy in asthmatic lung. EC. extract acts against the occlusion by reducing the inflammation in the tissue.
31 Effects of Ecklonia cava extracts on the recruitment of inflammatory cells into BAL(A) and airway responsiveness (B) in asthma mouse
(A) (B) 1200 50 Total cells SalineBlank OVAControl
/ml) 1000 EC. 4 Macrophages 40 OVA+EC Eosinophils 800 30 600 20 400
10 % Baseline Penh 200 0
Cells in in fluidBAL Cells x ( 10 0 Blank대조군 Control천식군 EC extract감태 0 2.5 5 10 50 Methacholine (mg/ml)
The number of macrophages and eosinophils increased in BAL fluids of control groups. But the cells in BAL fluid decreased in the EC extracts treated group. 32 Suppression of Th2 cytokine (A) and Ig E antigen (B) by EC. extract in asthma mouse model
(A) (B) 350 SalineBlank
300 Contro OVAl 1.5 250 OVA+ECEC.
200 1 specific IgE 150 - 100 0.5
Cytokines (pg/ml) Cytokines 50 Serum OVA Serum (OD units) 0 0 Blank Control EC extract IL-4 IL-5 TNF-α Saline OVA OVA+EC
The Th2 cytokines, IL-4, IL-5 and TNF-a, are important in the initiation and propagation of allergic inflammatory responses. The administration of EC extracts reduced the concentrations of IL-4, IL-5 and TNF-a compared with that of the control mouse. 33 Anti-allergy effect
34 Allergic mechanisms
The cross-linking of FcεRI with allergen-IgE complexes causes the release of inflammatory mediators such as histamines and prostaglandins from activated mast cells, which contributes to the allergic responses in asthma,.
35 Effects of dieckol on FcεRI mRNA and protein expression
(A) Blank 5 μM 10 μM 25 μM 50 μM FcεRI α chain
β-acitn
(B) Blank 5 μM 10 μM 25 μM 50 μM
FcεRI α chain
β-acitn
Dieckol showed the reduction of FcεRI α chain gene (A) and protein levels (B) in a dose-dependent manner.
36 Effects of dieckol on binding between IgE and FcεRI
80 85.66%
Blank Cell number Cell The cross linking between Fcε R1 with allergen-IgE is mainly 100 101 102 103 responsible for the allergic 100 μM 50 μM 80 80 reactions. 17.69% 21.14% At the highest concentration, the
Cell number Cell dieckol showed the strongest
Cell number Cell inhibition.
Relative cell number cell Relative 100 101 102 103 100 101 102 103 This data suggest that dieckol may 25 μM 12.5 μM 80 80 be useful for the prevention of 56.43% 66.56% allergic-IgE induced allergic reactions by inhibiting the release
Cell number Cell of histamine. Cell number Cell
100 101 102 103 100 101 102 103
Fluorescent intensity 37 In-vivo anti-atopic effects of EC extract
Positive control : Betamethasone 17,21,-dipropionate A
B atopic dermatitis Positive control EC extract
Dermal administration of Ecklonia cava extract remarkably reduced atoptic dermatitis in mice.
38 Anti-HIV Antioxidant
Ecklonia cava
Anti-allergic Anti-cancer
Anti-asthma Anti-osteoarthritis 39
Development of Marine Nutraceuticals
☞ There are various kind of bioactive substances in marine organism. But it is very difficult to develop them as a drug for human.
☞ There are extremely small quantities of bioactive substances and their structures are highly complex. It is very difficult to synthesize them. ☞ There are many latent bioactive materials in marine organism and seafood processing by-products such as proteins, lipids, carbohydrates and so forth. However, they are not ready to be used in their natural form.
☞ For the bioconversion of these latent bioactive materials, membrane bioreactor technology has several advantages.
☞ Specially, this technology is capable of producing bioactive compounds in massive scale, controlling important factors like molecular weight, continuous production and economical feasibility.
40 Potential ways of utilizing marine bioresources
Biological materials Food Medicine Marine vitamins Muscle
Head Water-soluble Bone/Skin calcium Collagen Intestine
Enzymes Microbial genes Microorganisms
Unutilized byproducts contain valuable bioresources and can be converted into value-added products as functional foods and nutraceuticals.
41 Total fish catch and processing statistics in Korea
Year 2010 (Ton) 2011 (Ton)
Total fish catch 3,348,184 3,244,288 Fresh fish consumption 591,866 421,828
Processed raw fish (processing rate) 2,030,474 (82%) 2,163,926 (87%)
Products (yield %) 1,510,474 (60%) 1,318,132 (53%)
Byproducts * (%) 965,714 (40%) 1,168,910 (47%)
* Byproducts : fish skin, fish bone, fish head, fish intestine, (crustacean shells, shellfish shells)
In South Korea, almost one million tons of seafood byproducts are generated annually from fish processing plants. Only a small percentage is recovered as value-added products. Therefore, there is a need to find methods utilizing these materials efficiently and more meaningfully.
42 Bioconversion of latent bioactive materials into active forms using bioconversion techniques
If we can change these latent bioactive materials into active forms using bioconversion techniques, they can perform remarkable functions in our body.
43 Structures of Chitin, Chitosan & Cellulose
Chitin Å° ƾ CH OH H NHCOCH3 2 H NHCOCH3 O H H O O H OH H OH H H H H When the degree of deacetylation in chitin is over OH H H O O H H O O 70%. The term, chitosan is prefered. H NHCOCH CH2OH 3 CH2OH Celluose is insoluble in water. Since the chemical structure of chitin and chitosan Å°Åä»êChitosan CH OH backbone are very similar to that of cellulose. H NH2 2 H NH2 O H H O O H Chitin and chitosan are also insoluble in water. OH H OH H H H H OH H H O O H H O O H NH CH2OH 2 CH2OH
¼¿·ê·Î¿À½ºCellulose H OH CH2OH H OH O H H O O H OH H OH H H H H OH H H O O H H O O H OH CH2OH CH2OH
44 ● Chitosan is known to have important functional properties in many area such as medicinal material, biopolymer, food, medicine and agriculture. Its application for industry is restricted because of poor solubility and absorption through the human intestine. ● Chemical and enzymatic methods are widely used in COS production approaches. Among them, chemical hydrolysis is used more commonly in the industrial-scale production.
● However, chemical hydrolysis has some drawbacks to be commercialized, due to the development of some toxic compounds, higher risk associated with the environmental pollution and lower production yields. ● Lack of proper technology for the large-scale manufacturing of COS with desired MW makes it difficult for human use in past years.
● The enzymatic processes are generally carried out in batch reactors and are preferable over chemical methods. However, the higher cost associated with hydrolytic enzymes reduce the application of the enzyme methods.
● Therefore, reuse of enzyme is recommended and sequential development is achieved in continuous production of COS in large scale.
45 Continuous production of chitooligosaccharides (COS) using an enzyme membrane reactor system
Pump Thermometer Stirrer Concentrate UF membrane Pump Drying
Chitooligosaccharides Enzyme reactor Supplement Reservoir tank tank
Water bath Pump
The entire reaction mixture is pumped continuously through the membrane module, where the product of the reaction, small enough to permeate through the membrane are removed, while the enzyme and other compounds rejected by membrane are recycled back to the reactor for further reaction.
46 Continuous production of COS using the membrane reactor system
한 Reactor 외
생물반 여
응기 과
막
$ 30 $150
Cross section of Outer wall surface the membrane of the membrane
Hallow fiber cartridge contains a large number of hollow fiber. Each hollow fiber has UF membrane which allow small particles to permeate while large particle could not permeate. 47 Molecular weight distribution profiles of different chitosan oligosaccharides obtained from membrane reactor system
COS I: 5~10 kDa COS II: 5~1 kDa COS III: <1 kDa 0.8 6.6 kDa 5.8 kDa COS I COS III COS II 8.5 kDa 1.5 Hexamer 0.6 3.7 kDa Pentamer
0.4 1.0 Heptamer
0.2 0.5 Absorbance at570 nm Absorbance Absorbance at570 nm Absorbance
0.0 0.0
20 40 60 80 100 20 40 60 Fraction number Fraction number
48 In vivo absorption of COS Rats were fed with FITC-labeled chitosan After 30 min, epithelium of duodenum and jejunum was dissected and observed through a (original magnification: ×100) confocal microscope
Duodenum (3.8 kDa) Jejunum (3.8 k Da) Duodenum (7.5 kDa) Jejunum (7.5 k Da)
Duodenum (13 kDa) Jejunum (13 k Da) Duodenum (22 kDa) Jejunum (22 k Da)
Absorption of COS was significantly increased by their low MW
49 Biological activities of chitooligosaccharides (COS)
Anti-microbial activity Anti-tumor activity Antioxidant activity Enzyme inhibitory activity (MMP, β-secretase, ACE)
50 Antibacterial activities of chitosan and COSs
Bactericidal activity (%) Bacteria Chitosan COS I COS II COS III MW 5-10 kDa MW 1-5 kDa MW < 1 kDa
Streptococcus mutans 100 ± 0 100 ± 0 99 ± 0 99 ± 0 Micrococcus luteus >99 ± 0 70 ± 0 67 ± 3 63 ± 7 Staphylococcus aureus 100 ± 0 97 ± 3 95 ± 0 93 ± 9 Bacillus subtilis 98 ± 2 63 ± 5 60 ± 5 63 ± 7 Escherichia coli O-157 >99± 0 71 ± 3 56 ± 4 60 ± 2 Escherichia coli >98± 0 98 ± 5 62 ± 5 51 ± 7 Salmonella typhi >99 ± 0 91 ± 0 88 ± 0 89 ± 0 Pseudomonas aeruginosa 68 ± 3 47 ± 5 35 ± 5 22 ± 8
Chitosan showed stronger bactericidal effects on all bacteria tested except Pseudomonas aeruginosa. The three oligosaccarides have also significantly inhibiting the growth of the bacteria although their effects were lower than that of chitosan.
51 MICs of chitosan and COSs against several virulent bacteria
0.5
Chitosan 0.4 COS I COS II COS III 0.3 MIC(%) 0.2
0.1
0 Str. mutans St. aureus B. subtilis M. luteus St. epidermidis
COS I: 5~10 kDa COS II: 1~5 kDa COS III: <1 kDa
MIC value of chitosan were less than 0.06%. COS were able to inhibit same species effectively. All samples MIC values for Str. mutants were below 0.04% unrelated to molecular weight.
Streptococcus mutants which induces dental caries was completely inhibited by COS, suggesting that gargling with a COS solution, preventing our teeth from decaying. 52 Antifungal effects of chitosan and COSs prepared with different molecular weights
(a) Aspergillus niger (b) Alteraria mali
Chitosan Chitosan COS I COS I
Control Control
COS II COS III COS II COS III
COS I: 5~10 kDa COS II: 5~3 kDa COS III: <1 kDa
No fungal growth was visible in cultures treated with chitosan. COS also has an antifungal effect. The higher Mw of COS, the greater antifungal effect.
53 Biological activities of chitooligosaccharides (COS)
Anti-microbial activity Anti-tumor activity Antioxidant activity Enzyme inhibitory activity (MMP, AchE)
54 Effect of COSs on the growth of implanted sarcoma 180 and uterine cervix carcinoma tumor cells in mice
Sarcoma 180 tumor cells Uterine cervix carcinoma tumor cells Sample Dose Number Tumor weight Inhibition Tumor weight Inhibition (mg/Kg/day) of mice (mg) rate (%) (mg) rate (%)
Control 12 1032.5 ± 839.5 912.2 ± 612.1 COS I 50 12 1147.0 ± 933.9 - 965.2 ± 839.7 - (5~10kDa) 20 12 901.0 ± 741.7 12.7 803.3 ± 641.8 11.9 10 12 795.5 ± 384.8* 22.9 772.7 ± 592.2 15.3 COS II 50 12 345.2 ± 218.6* 66.6 240.5 ± 202.5* 73.6 (1~5kDa) 20 12 665.6 ± 340.1 35.5 352.3 ± 331.1 61.4 10 12 739.5 ± 351.8 28.4 669.5 ± 562.3 26.6 COS III 50 12 904.0 ± 510.3 12.4 665.0 ± 477.9 27.1 ( < 1kDa) 20 12 874.8 ± 516.6 15.3 841.1 ± 602.1 7.8 10 12 973.5 ± 417.1 5.7 879.9 ± 650.3 3.5 * P<0.05 versus the control group
Among three kinds of COSs tested, COS II effectively inhibited the growth of both types of tumor. Therefore it is clear that MW of COS is very important for anticancer activity.
55 Comparison of COSs on survival effect of BALB/c mice implanted subcutaneously with sarcoma 180 cell
16 Control COS I 14 COS II COS III 12 10 8
6 88.5% 4 Number of of Number survival mouse 2 69.7% 30.4% 0 10 15 20 25 30 35 40 45 50 Survival days
There were no survivors in the control group after 30days, however the groups treated with COS II exhibited extremely higher survival prolongation rates 88.5%.
56 Effects of COSs on the gene expression of MMP-1 in human dermal fibroblasts
G3PDH
MMP-1
Intergrated density value of MMP-1 PCR products
250000
200000
150000
100000
50000
0 Blank Control COS <1KDa COS 1KDa~3KDaCOS 3KDa~5KDa COS 5KDa~10KDa
MMP-1 mRNA expression clearly exhibited that COS with 3-5 kDa is effective in controlling the expression of MMP-1 compared to the other MW of COS.
57 Effects of COSs on MMP-9 in human dermal fibroblasts
BK PMA 50 100 500 1000 µg/ml
MMP-9
activity(%) 9 MMP - Intensitive value (%) value Intensitive
PMA (Phorbol miristic acetate) : Stimulator of MMP
MMP-9 is also a very important enzyme that activates specially during metastasis of cancer. We identified that MMP-9 can also be inhibited by COS.
58 Biological activities of chitooligosaccharides (COS)
Anti-microbial activity Anti-tumor activity Antioxidant activity Enzyme inhibitory activity (MMP, β-secretase, AchE)
59 Free Radicals and Reactive Oxygen Species
Antioxidants
Living organisms Foods
• Inflammation • Rancidity • Diabetes • Arthritis • Off-flavor • Parkinsonism • Structural instability • Cancer • Shorter shelf-life • Aging
60 Effect of COSs with different MW on scavenging of radicals using electron spin resonance (ESR)
Control COS < 1 kDa COS 1-3 kDa (100 ug/ml) Hydroxyl radical
Superoxide radical
Carbon-Centered radicals
COS bearing below 1 kDa molecular weight could scavenge hydroxyl, superoxide and alkyl radicals better than that of 1-3 kDa COS.
61 Effect of COSs on inhibition of intracellular generation of ROS in melanoma cells
6000 (C) 100 µg/ml 5000
4000 ** Melanoma (B16F1) ** cells were treated with 3000 ** ** COS and intracellular ** formation of ROS was 2000 ** ** assessed using 1000 ** oxidation sensitive dye, DCFH-DA( 2′,7′- DCF intensity fluorescence 0 dichlorofluorescin diacetate) 0 30 60 90 120 Time(min)
Low MW COS, generation of intracellular radicals was greatly reduced with time.
62 Inhibition of DNA oxidative damage by COS
COS <1 kDa (µg/ml) Genomic DNA from H2O2 10 50 100 500 BLK (2 mM) B16F1 cells was pre- treated with COS and exposed to hydroxyl radicals.
After 30 min, DNA was electrophorased on a 1% agarose gel and visualized with EtBr
DNA damage was protected by low MW COS which was dose dependent.
63 Protective effect of COS on the damage of pancreas cancer cells induced by streptozotocin.
Control
STZ
COS
NIT-1 cells : pancreas cancer cell
Photomicrograph of NIT-1 cells DNA migration in different experimental groups (× 200).
STZ induces pancreas cancer cells to be damaged by oxidative stress and undergo DNA migration. However, COS addition protects pancreas cancer cells from STZ-induced cell damage due to its anti- oxidant effect. 64 Development of Bio-active Peptides
65 Schematic diagram of the three-step recycling membrane reactor for the preparation of bioactive peptides from fish processing byproducts
PCV PCV PCV
pHIC pHIC pHIC NaOH FI NaOH FI NaOH FI T T T
PI PI PI Protein solution FSEH SSEH TSEH Heater Heater Heater
This system enables consecutive digestion of protein using different specific enzymes and simultaneous separation of products, based on their MW using UF membranes.
66 ACE inhibitory peptides purified from different fish protein hydrolysates using UF membrane system
Protein source Peptide IC50 (uM) AP skin collagen Gly-Pro-Leu 2.65 a AP skin collagen Gly-Pro-Met 17.13 a AP frame protein Phe-Gly-Ala-Ser-Thr-Arg-Gly-Ala 14.7 b YF skin collagen Met-Ile-Phe-Pro-Gly-Ala-Gly-Gly- Pro-Glu-Leu 10.75 c YF frame protein Arg-Pro-Asp-Phe-Asp-Leu-Glu- Pro-Pro-Try 15.02 d Soy protein Pro-Try-Gly-Ala-Glu 22.56 e Spinach protein Leu-Pro-Leu-Gly-Pro 18.76 f
IC50: Half maximal (50%) AP: Alaska pollack, YF: Yellowfin sole inhibitor concentration
Angiotensin I converting enzyme (ACE) plays an important physiological role in regulating blood pressure.
67 Effect of ACE inhibitory peptides on systolic blood pressure of spontaneously hypertensive rat (SHR)
(Alaska pollack skin gelatin peptide) : Gly-Pro-Leu
Peptide
- Single oral administration was performed with the dose of 10 mg/kg of body weight - Systolic blood pressure was measured at 0, 1, 2, 3, 6 and 9 h after the administration.
The peptide exhibited a similar potency to Captopril in reduction of the systolic blood pressure of SHR.
68 Antioxidative peptides purified from different fish protein hydrolysates using UF membrane system
Fish protein derived peptide sequences that are capable of acting as antioxidants.
69 Antioxidant activity of purified peptide from hoki skin collagen in linoleic acid oxidation system
RSP
Radical-scavenging peptide (RSP) purified from Hoki skin collagen
His-Gly-Pro-Leu- Gly-Pro-Leu (797 Da)
Antioxidant activity of purified peptide was higher than α-tocopherol in linoleic acid oxidation system.
70 Protective effect of the purified peptide from oyster hydrolysate against hydroxyl-radical-induced DNA damage
Purified peptide from oyster hydrolysate Leu-Lys-Gln-Glu-Leu-Glu-Asp-Leu-Leu-Glu-Lys-Gln-Glu (1.60 kDa)
FeSO4 & H2O2 Blank Control 45.6 uM 22.8 uM 5.7 uM
OC DNA : Open circular DNA, SC DNA : Super coiled DNA
DNA damage was protected in the presence of purified peptide dose dependently.
71 Water soluble calcium from fish bone
Fish processing byproducts
$ 1 / kg
Homogenization Extract of fish crude Treatment of fish crude intestinal enzyme intestine enzyme
Water Soluble Calcium
$ 50~100 / kg
72 Calcium ion transferring and influx activity using confocal laser scanning microscope
Confocal Laser Scanning Microscope image
Commercial Casein phosphopeptide Soluble Ca from Products (CPP) fish bone
Water soluble calcium showed strong calcium transferring and influx activity in Osteoblast like CPP which is a famous commercial calcium accelerator.
73 Measurements of the strength of femur after 4 week diets
14
12
10
8
6
Strength of femur (kg) femur of Strength 4
2
0 A B C D
A, lack of Ca; B, Commercial products; C, soluble Ca from fish bone; D, soluble Ca + P-peptides
Water soluble calcium treatment group showed enhanced strengths of femurs compared to commercial products. Furthermore water soluble calcium and CPP mixed treatment group showed slight synergy effect.
74 Bone densities of femur after 4 week diets using SEM image
Lack of Ca Soluble Ca from fish bone
We can identify the remarkable increasing of bone density in water soluble calcium treatment group.
75 Hair growth effect
76 Hair growth effect of IGF-1 in hair dermal papilla cells
Hair cycle
Source: Relevant Research, Inc.International Society of Hair Restoration Surgery, 2013
Insulin-like growth factor-1 (IGF-1)
Sites of action of androgenetic alopecia treatment drugs Promotion of forliferation of hair papilla cell
Release of growth factors such as IGF-1, Baldness prevention and HGF, FGF-7. etc. improvement
In the hair roots, CGRP acts on the hair papilla cells, and the hair paliia cell produces IGF-1, to promote cell division of the hair pailla cell, to grow hair , and to promote hair restoraton!77 777 Effect of marine alga extract on dermal papilla cells, hair shaft elongation and hair follicles
(a) (b) μg/ml
Control E.cottonii (c)
DAPI IGF-1 DAPI IGF-1 Control E.cottonii
DAPI : 4'-6-Diamidino-2-phenylindole staining Effect of marine alga extract on dermal papilla cells (a)hair shaft elongation (b) and hair follicles gene expression (c) fluorcent image of DAPI and IGF-1 staining in hair follicals 78 Growing phase induction effect of marine alga extract on C57BL/6 mice
5 weeks after treatment
Extract treated group show a clear induction of growing phase and increase in hair shaft elongation which means that E.cottonii extract has restored the hair growth cycle. 79
Effect of marine alga extract on human subjects in clinical tests
1. Hair density
Tonic containing 1% of seaweed extract 0 day 16 Week
Control
Sample E. cottonii : Hydroxydihydrobovolide
Sample treated area showed elevated hair density compared to the control. 80 Effect of marine alga extract on human subjects in clinical tests
2. Hair diameter
0 day 16 week
Control
m) μ Diameter(
Sample 16 week
Sample Control
Hair diameter is also increased by sample treatment compared to control group. 81 Effect of marine alga extract on human subjects in clinical tests
3. Hair growth rate
Tonic containing 1% of seaweed extract 0 day 16 week
Control
Sample
16 week
Sample Control Hair shafts are longer compared to control group. This tonic can be produced as a commercial product for hair loss. 82 Erectile Dysfunction
83 Mechanism of Sexual Dysfunction
60
50
40
30
20
10
0 Erectile dysfunction dysfunction (%) incidence Erectile
The Global Study of Sexual Attitudes and Behaviors (GSSAB), 2011
-NO activates the guanylate cyclase which converts GTP to cGMP cGMP induces erection
84 84 Effect of Urechis unicinctus on NO and GTP production for an erection of the penis
A) NO assay Urechis unicinctus
- lives in soil or mud - eaten raw with salt and sesame oil in Korea DDL (Asp-Asp-Leu)
3000 1.2 B) C) 2500 1.0
2000 0.8
0.6 1500 p
0.4 1000
0.2 500 NO production (%) GTP [Phosphate] [Phosphate] (μM) GTP 0.0 0 Blank Control 개불 Blank Control 개불 Blank Control Urechis unicinctus Blank Control Urechis unicinctus Nitric Oxide production in Urechis unicinctus using the NO assay GTP production in Urechis unicinctus using the ATP assay Urechis unicinctus enhances the NO and GTP production
85 Effect of Urechis unicinctus on eNOS and iNOS production in vascular endothelial cells
eNOS and iNOS are important modulators of NO production related to erection. Sample treatment increased both eNOS and iNOS expression in a dose dependant manner. At the concentration of 1000 ug/ml, expression eNOS was almost 6 times higher than control.
86 In-vivo improving sexual dysfunction effects of Urechis unicinctus extract
Evaluation of sexual dysfunction
Mount Glooming Ejaculation
number number number
Mount Glooming Ejaculation Mount Glooming Ejaculation Mount Glooming Ejaculation
Control 500 mg/kg Cialis
Sexual dysfunction effects of U. unicinctus extract and cialis treatment group were almost similar. This extract could replace synthetic drugs. Because it is safe to use and shows similar effects to commerical drugs. 87 Clinical tests of Urechis unicinctus extract
A randomized, placebo-controlled, double-blind, single-center clinical trial to evaluate the efficacy and safety of Urechis unicinctus extract(UU104) compared to placebo with male hypogonadism
- AMS score (Aging Males’ Symptom Score) variation - Total testosterone variation
- IIEF (International Index of Erectile Function) variation - IPSS (International Prostate Symptom Score) variation
Oral administration of Urechis unicinctus extract shows better activity than control group 88 89 Edited Books
Marine Bioenergy / CRC press Taylor and Francis Group - December 1, 2014
Handbook of Anticancer Drugs from Marine Origin / Springer
Functional Marine Biomaterials - Properties and Application / Woodhead publishing
Marine Algae Extracts / Willey
Handbook of Marine Microalge / Academic Press
Marine Carbohydrates / Academic Press
Marine Omics / CRC Press
Marine Microorganisms : Interaction and analysis of bioactive compounds / CRC Press
Marine Glycobiology : Principle and Application / CRC Press
Encyclopedia of Marine Biotechnology / Willey
90 Bioactive materials from marine organism
Functional Food Anti-hypertension food Anti-asthma food
Hair growth tonic Liver Functional Food Anti-diabetes mellitus food Functional Cosmetics
92 Bioactive materials from marine organism
Microfluidics chip Antihypertensive food Erectile Dysfunction food Sleep improve food
Marine time hair treatment Marine time skin whitening & wrinkle free
93 Summary
Marine organisms live in an extreme environment and there produce novel fascinating and unique bioactive compounds which could not be produced by terrestrial organisms.
We have investigated and developed various marine derived bioactive compounds for variety of biological activities such as anti-inflammatory, anti-H I V, anti-asthma, anti-allergy, sexual dysfunction, hair growth effect and sleep promoting effect. So much attention has been paid on marine bioactive compounds to treat chronic diseases which can be developed as commercial products.
Chemical synthesis of natural products will be an alternative for industrial commercial applications and those that cannot synthesized marine bioactive compounds can be used as oriental medicine
Finally much attention to be paid on marine organism collections for the development of high value added products in industrial scale.
93 Location: south east of korea.
Pukyong National Univeristy
Busan
Area: 765.94 Km2 Population: 3,586,079 (‘12.12.31) Fire festival
Gwanganbridge Haundae beach
Gwangan beach 96 Jagalchi market
Shinsegae department store
APEC house Film festival BIFF Post Doctors
Dr. Kyong-Hwa Dr. J. Venkatesan Dr. Yong-Xin Li Dr. Fatih Dr. Mani Dr. Vo Thanh Dr. Ngo Dai Kang Karadeniz Sang Hung Prof. Se-Kwon Kim
Lab Scholars
Ta Van Yong-Sang Kim Soyeon Kim Babuka Se-Hun Oh Alarm Jun Ho Hyoung Woo Sung Han Ding Su Kyoung Heo Quang
98